Syneron-Candela Presents 3 new Products at the 22nd World Congress of Dermatology in Seoul, Korea to Optimize Treatments That Respond to the Highest In-Demand Aesthetic Treatments of Asian Consumers

Wednesday, June 1, 2011 General News
Email Print This Page Comment bookmark
Font : A-A+

YOKNEAM, Israel, May 31, 2011 /PRNewswire/ -- Syneron Medical Ltd. (NASDAQ: ELOS) held a media panel on the specific

challenges of Asian skin and ways to successfully satisfy the increasing demands of Asian consumers regarding skin tone and appearance.

"Many people believe that the most important differences in skin type are related to color or texture,"

said Bang Soon Kim, MD, Co-Director S&U Dermatological Clinic. "The truth of the matter is that differences in skin according to ethnic origin are much more complex and Asian skin has its own unique characteristics and requirements for which specific treatments and products are needed."

"In our efforts to bring the best possible aesthetic solutions to physicians and their patients around the world, we are proud to present at this World Congress innovations that are particularly geared towards the needs of Asian skin," announced Louis P. Scafuri, Chief Executive Officer of Syneron. The unique and novel technologies that Syneron will be presenting, at this year's World Congress of Dermatology, include elureTM, ePrimeTM and eMatrix(R). All three of these products are able to take into consideration the specific requirements of Asian skin.


The elure Advanced Skin Lightening Technology(TM) is the first and only topical skin lightening product that improves appearance by temporarily breaking down melanin, the pigment that accumulates in the skin to cause a darkened or uneven skin tone. Using a novel natural enzyme called Melanozyme(TM), the elure system delivers rapid improvement in skin appearance, creating healthier, brighter and younger-looking skin in less than 30 days, with an excellent safety profile and very high tolerability.

The results of elure have already been proven with multi-center studies throughout the world and the effectiveness and safety on Asian skin has been demonstrated.

In his presentation during a Syneron sponsored media panel at the World Congress of Dermatology today, Alain Khaiat, PhD - President of Seers Consulting, announced that "our clinical trial data confirms that elure has an ideal profile for meeting more quickly and safely the demands of Asian skin. It is perfectly suited for both men and women for whom the reduction of skin hyper-pigmentation irregularities contributes to greater self-esteem and quality of life."


This revolutionary facial treatment device is particularly well adapted to the needs of Asian skin thanks to the unique technology employed in this procedure. Given the greater tendency of Asian skin to form unsightly scars through cosmetic laser procedures, it is important to understand the exact impact of various devices on Asian skin. This is exactly what Syneron has done with its ePrime energy-based dermal remodeling system. "We are deeply impressed with the way in which the ePrime minimally invasive technology allows us to deliver measured Radio Frequency energy directly into the deep dermis for noticeable improvement to skin tone and volume without any damage to Asian skin," said Henry Hin Lee Chan, MD, PhD, Hong Kong Dermatology and Laser Centre.


Another one of Syneron's RF based devices that ensures safe and effective treatment of Asian skin, is the revolutionary eMatrix Sublative Rejuvenation - Fractionated bipolar Radio Frequency device. Its ability to produce significant dermal impact with minimal epidermal damage, allows it to be highly effective for improving wrinkles, skin laxity, textural irregularities and for reducing disgraceful scarring or skin lesions of various origins. Its minimal epidermal disruption provides a competitive advantage that is particularly important when treating Asian skin.

With growing demands in Asia for products and services that improve skin appearance, Syneron Medical Ltd. already offers ideal solutions with fast visible results, whether for skin whitening or for skin rejuvenation. "Innovation is what drives our business, said Shimon Eckhouse, co-founder and Chairman of Syneron Medical Ltd. and we are investing heavily in research to meet the specific needs of Asian skin." With the greatest growth in the aesthetic market coming from Asia, it is important to know that Syneron is continuously working closely with the Asian medical community to remain at the forefront of the best possible products and technology for Asian skin.

About Syneron Medical Ltd.

In 2009, Syneron Medical Ltd. and Candela Corporation merged to create the global leader in the medical aesthetic devices market with both a short and long-term vision for developing this market. The strong financial base and aligned resources, allow this newly formed company to offer customers the broadest available product portfolio, the best global service organization and an expansive worldwide distribution network. With new breakthrough technologies currently in the pipeline, Syneron is ideally positioned to maintain its global leadership and continue to help physicians grow their practice.

Media contacts: - Tel. +33-141867626; Mobile: +33-607594395 -Tel. +82-2-513-1879; Mobile: +82-10-9322-2678

SOURCE Syneron-Candela


Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store